Here’s what you should know.
1. Mr. Saunders presented at the 35th annual J.P. Morgan Healthcare Conference where he said the company has a goal “to have a very strong balance between R&D deals and accretive deals.”
2. Allergan announced its intent to acquire LifeCell Corp. for $2.9 billion on Dec. 20, 2016.
It also recently bought out Vitae Pharmaceuticals for $639 million.
3. Mr. Saunders said the company’s six therapies currently in phase 3 development could be worth up to $13 billion in peak sales.
4. Between 2016 and 2017, Allergan plans to launch 11 new products. Predictions say the launches could generate approximately $5 billion in sales for the company.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Bradley Zins of the Billings Clinic
ASGE certifies Mercy Hospital: 3 things to know
Dr. Brian Davis hosts video on The Fundamentals of Endoscopic Surgery exam
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
